Understanding the Complexity of Oncology Drug Pricing
October 31st 2022Brian Corvino, MBA, managing director, Life Sciences and Health Care Practice, Deloitte Consulting, LLP, offered an overview of how the surge of innovation in oncology—and resulting drug approvals—dominate the biopharmaceutical sector. He spoke at the Community Oncology Alliance's Payer Exchange Summit.
Read More
Redesigning Benefits, Value-Based Agreements With Better Cancer Care in Mind
October 29th 2022The quest to deliver better cancer care—with better outcomes and patient experience—is not a one-size-fits-all journey, as seen in panels during the Community Oncology Alliance (COA) Payer Exchange Summit, held in Tyson’s Corner, Virginia.
Read More
Cancer Payment Models Improve Care, but Making Them Work Takes Effort
October 27th 2022Making value-based payment models work in cancer care requires close attention to the financial and quality measures and a commitment to culture change, said experts gathered October 25 at the Community Oncology Alliance Payer Exchange Summit.
Read More
EOM Creates a Heavy Lift for Small Practices, Leading Oncologists Say
October 26th 2022Panelists who have reviewed the Enhancing Oncology Model (EOM) say it puts additional requirements on practices with reduced monthly payments, and its risk modeling could put a small practice out of business.
Read More
Angela Storseth-Cooper Describes PBM Influence in Community Oncology, State-Level Interventions
March 24th 2022Angela Storseth-Cooper, associate director, Government Relations & Public Policy, The US Oncology Network, discusses state-level legislation that community oncology practices can leverage to address issues involving pharmacy benefit managers and the vertical integration of health plans and specialty pharmacies.
Read More
At the 2022 Community Oncology Conference, Elizabeth Spurlock, MA, PHR, director, Human Resources Business Partner, Texas Oncology, discussed the prevalence of burnout among physicians, staff, and administrators, and several strategies to reduce risk and support the health care workforce.
Read More
Why Measures Matter—and How to Inspire Cancer Practices to Use Them
March 19th 2022Quality measures are the lifeblood of practice transformation, but learning which ones make a difference—and how to use them to drive change—is as much an art as a science, according to 3 oncology care leaders who discussed the topic Friday at the 2022 Community Oncology Conference, presented by the Community Oncology Alliance.
Read More
Dr Lalan Wilfong Addresses Influence, Future Use of HEOR in Community Oncology
March 18th 2022Lalan Wilfong, MD, vice president of Payer Relations & Practice Transformation at The US Oncology Network, speaks on how use of health economics and outcomes research has benefitted patient care in the community oncology setting and where it can be further leveraged in the pursuit of value-based care.
Read More
Prior Authorization Woes Could Lead to Lawsuit, Former AMA President Says at COA
March 18th 2022Barbara McAneny, MD, CEO of the New Mexico Cancer Center, who served as president of the American Medical Association (AMA) in 2018, said the AMA has engaged a law firm to take on the issue of curtailing prior authorization, which oncologists say has become worse with increased vertical integration among health plans and pharmacy benefit managers.
Read More
Ben Jones Discusses Federal-, State-Level Policies to Promote Value-Based Community Oncology Care
March 17th 2022Ben Jones, vice president, Government Relations & Public Policy, The US Oncology Network, addresses potential reform at the federal and state level that could accelerate the pursuit of value-based care in the community oncology setting.
Read More
Dr Michael Diaz on the Importance of Site of Care, PBM Reform
March 17th 2022Michael Diaz, MD, president and managing physician, Florida Cancer Specialists & Research Institute, speaks on takeaways from his discussions on site of care and pharmacy benefit managers (PBMs) at the 2022 Community Oncology Conference.
Read More
No One Left Behind, a program to provide financial assistance and access to cancer care at Carolina Blood and Cancer Care Associates in South Carolina, will be discussed during a session of the Community Oncology Alliance 2022 Community Oncology Conference.
Read More
Dr Kashyap Patel on Health Equity Discussion at the 2022 Community Oncology Conference
March 14th 2022Kashyap Patel, MD, chief executive officer, Carolina Blood and Cancer Care Associations, and current president of the Community Oncology Alliance (COA), previews his discussion on health equity to be held at the 2022 Community Oncology Conference.
Read More
Glenn Balasky Previews Discussion on Building Community Oncology Practice for the Future
March 11th 2022Glenn Balasky, executive director of Rocky Mountain Cancer Centers, previewed topics and potential takeaways from his discussion on building a community oncology practice for the future at the 2022 Community Oncology Conference.
Read More
Dr Kashyap Patel Discusses Benefits of In-Person Community Oncology Conference
February 28th 2022Kashyap Patel, MD, CEO of Carolina Blood and Cancer Care Associates, and current president of the Community Oncology Alliance (COA), speaks on what he’s looking forward to for his first in-person Community Oncology Conference as COA president.
Read More
Pricing, Payment Reform, and Politics Are Inextricably Linked in Cancer Care
April 9th 2021On day 2 of this year’s Community Oncology Conference, a panel of government and health policy experts gathered to discuss the hot-button issue of political influence on cancer policy and the damage community oncology has suffered this past year.
Read More
Patients Are the “Value” Focus in Cancer Care, Panelists Agree
April 9th 2021There are many sources, and definitions, of where the value in cancer care lies. In this panel discussion, a cancer survivor and patient advocate, an oncologist, and a benefits professional provided their perspectives on what value in cancer care means to them.
Read More
Dr Lalan Wilfong Discusses Growth in Remote Monitoring, Future of Value-Based Cancer Care
April 9th 2021Lalan Wilfong, MD, executive vice president, Value Based Care & Quality Programs, Texas Oncology, and cochair, Payment Reform, Community Oncology Alliance, speaks on the evolution of remote monitoring in cancer care and how value-based oncology may look in the near future.
Read More